Archive for September 2025
Study Published in the Journal Infection Demonstrates Clinical Utility of SeptiCyte® RAPID to Diagnose Sepsis in Critically Ill Patients with Hospital Acquired Infections
From the PR Newswire post SeptiCyte® RAPID outperformed traditional inflammatory biomarkers of procalcitonin and C-reactive protein SEATTLE and BRISBANE, Australia, Sept. 17, 2025 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced the publication of a study in the journal Infection. The article, entitled, “Blood transcriptomic for the diagnosis of nosocomial…
Read MoreRollie Carlson Discusses Host Response Testing Gains Attention in Sepsis Diagnosis and Antibiotic Stewardship
Excerpt from a discussion with Tero Vesalainen from CLPMag. A recent poll highlights growing interest in host response testing for sepsis. Immunexpress CEO Rollie Carlson discusses the findings and the future of rapid diagnostics. In a recent poll conducted by Immunexpress following a Sepsis Alliance webinar, 73% of healthcare professionals and patient advocates said they believe host…
Read More